Skip to main navigation Skip to search Skip to main content

Doxazosin inhibits monocyte chemotactic protein 1-directed migration of human monocytes

  • Ulrich Kintscher
  • , Dedrick Kon
  • , Shu Wakino
  • , Stephan Goetze
  • , Kristof Graf
  • , Eckart Fleck
  • , Willa A. Hsueh
  • , Ronald E. Law

Research output: Contribution to journal › Article › peer-review

Abstract

Monocyte chemotactic protein 1 (MCP-1)-directed transendothelial migration of monocytes plays a key role in the early development of atherosclerosis. Migration of monocytes requires degradation of extracellular matrices, a process that involves matrix metalloproteinases (MMP) and tissue inhibitors of MMPs (TIMP). Recent studies suggest that the α1-adrenergic receptor antagonist doxazosin (Dox) might have antiatherosclerotic effects, although the underlying mechanisms are poorly understood. The purpose of the present study was to determine the effects of Dox on MCP-1-directed monocyte migration, MMP-9 activity, and TIMP-1 expression. MCP-1 (50 ng/ml) stimulated migration of human peripheral blood monocytes (HPBM) 2.7 ± 0.42-fold and THP-1 human monocytes 5.9 ± 0.83-fold compared with unstimulated control. Dox inhibited MCP-1-induced migration in a dose-dependent manner, with a maximal reduction at 10 μM of 69.5 ± 5.9% in HPBM and 72.2 ± 3.2% in THP-1 cells. Dox blocked migration even after pretreatment with phenoxybenzamine, an irreversible α1-adrenergic receptor antagonist (HPBM: phenoxybenzamine 1 μM + Dox 10 μM, 71.9 ± 2.2% inhibition; THP-1 cells: phenoxybenzamine 1 μM + Dox 10 μM: 78 ± 7.7% inhibition), suggesting that the antimigratory activity of Dox is mediated through a novel mechanism unrelated to its blocking of the α1-adrenergic receptor. Dox (10 μM) inhibited MMP-9 activity by 67.6 ± 10.5%, whereas MMP-9 protein levels were not affected. Also, Dox increased PMA-induced-tissue inhibitor of MMPs-1 (TIMP-1) expression by 134.4 ± 6.6%. Dox 10 μM. The present study demonstrates a potential novel antiatherosclerotic action of Dox by blocking MCP-1-directed monocyte migration, which might be partly mediated by inhibition of MMP-9 activity.

Original languageEnglish
Pages (from-to)532-539
Number of pages8
JournalJournal of Cardiovascular Pharmacology
Volume37
Issue number5
DOIs
StatePublished - 2001

Keywords

  • Doxazosin
  • Matrix metalloproteinase
  • Migration
  • Monocyte
  • Tissue inhibitors of matrix metalloproteinase

Fingerprint

Dive into the research topics of 'Doxazosin inhibits monocyte chemotactic protein 1-directed migration of human monocytes'. Together they form a unique fingerprint.

Cite this